Longbow Finance SA »

Mink Therapeutics shares owned by Longbow Finance SA

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Longbow Finance SA from 13F filings

Historical chart of Longbow Finance SA investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Longbow Finance SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Longbow Finance SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $151k 167k 0.91
2023-12-31 $178k 167k 1.07
2023-03-31 $316k 167k 1.90
2022-12-31 $435k 167k 2.61

More positions owned by Longbow Finance SA

Select Sector SPDR Fund Consumer Discretionary (XLY)
Select Sector SPDR Fund Industrial (XLI)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
NVIDIA Corporation Common Stock (NVDA)
Alphabet Class C Capital Stock (GOOG)
Exxon Mobil Corporation Common Stock (XOM)
Meta Platforms Class A Common Stock (META)
JPMorgan Chase & Co. Common Stock (JPM)
Eli Lilly and Company Common Stock (LLY)
Amazon.com Common Stock (AMZN)
Berkshire Hathaway Class B Common Stock (BRK.B)
Visa Class A Common Stock (V)
Select Sector SPDR Fund Utilities (XLU)
Occidental Petroleum Corporation Common Stock (OXY)

View all positions for Longbow Finance SA

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Geode Capital Management
BlackRock
Captrust Financial Advisors
HighTower Advisors
Susquehanna International
Citadel Advisors
Millennium Management
Goldman Sachs Group
Northern Trust
Tower Research Capital
Wells Fargo & Company
UBS Group
Bank of America Corporation

View all funds holding Mink Therapeutics